MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced the in-licensing of a next-generation selective ...

Plant-based meats are healthier options for enjoying your favorite meals. But are these alternatives as wholesome and ...

Bihar Board 12th Biology model sample papers for the 2025 board exams are out at biharboardonline.com. Get here Bihar board ...

IMP-1734 is under development for the treatment of solid tumors, metastatic breast cancer, ovarian cancer, fallopian tube cancer, primary peritoneal cancer and metastatic castrate resistant prostate ...

Pancreatic cancer is a highly lethal digestive malignancy with a 5-year survival rate of 10%. So far, the available therapeutic strategies are scarce and the few advancements made, as is the case of ...

Her team recently developed a small nanocarrier that actively delivers a poly (ADP-ribose) polymerase (PARP) inhibitor and a ...

D-Ribose is a naturally occurring pentose sugar essential for the synthesis of adenosine triphosphate (ATP), the primary energy carrier in cells. Unlike other carbohydrates, D-Ribose plays a critical ...

Smart TVs have become the norm, offering features beyond the basic TVs of old. But finding a TV that doesn’t connect to the internet, stream video content, and respond to voice commands is ...

Twitter alternatives — new and old — have found audiences willing to try out a newer social networks since Elon Musk took over the company in 2022. Mastodon, Bluesky, Spill and T2 are some of ...

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced funding for a new project ...

Poly (ADP-ribose) polymerase (PARP) inhibitors are used as maintenance therapy after completion of platinum-based chemotherapy in ovarian cancer. However, acquired or de novo resistance to PARP ...

Fig 2. Approximately week 90; 7 weeks into second round of gemcitabine/docetaxel treatment. Fig 3. Approximately week 109; roughly 1 week before starting niraparib (poly(ADP-ribose) polymerase ...